• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

弥漫性胸膜间皮瘤:分子发病机制、诊断和治疗的进展。

Diffuse Pleural Mesothelioma: Advances in Molecular Pathogenesis, Diagnosis, and Treatment.

机构信息

Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA; email:

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

出版信息

Annu Rev Pathol. 2024 Jan 24;19:11-42. doi: 10.1146/annurev-pathol-042420-092719. Epub 2023 Sep 18.

DOI:10.1146/annurev-pathol-042420-092719
PMID:37722697
Abstract

Diffuse pleural mesothelioma (DPM) is a highly aggressive malignant neoplasm arising from the mesothelial cells lining the pleural surfaces. While DPM is a well-recognized disease linked to asbestos exposure, recent advances have expanded our understanding of molecular pathogenesis and transformed our clinical practice. This comprehensive review explores the current concepts and emerging trends in DPM, including risk factors, pathobiology, histologic subtyping, and therapeutic management, with an emphasis on a multidisciplinary approach to this complex disease.

摘要

弥漫性胸膜间皮瘤(DPM)是一种起源于覆盖胸膜表面的间皮细胞的高度侵袭性恶性肿瘤。虽然 DPM 是一种与石棉暴露有关的公认疾病,但最近的进展扩展了我们对分子发病机制的理解,并改变了我们的临床实践。本综述探讨了 DPM 的当前概念和新兴趋势,包括危险因素、病理生物学、组织学亚型和治疗管理,重点是对这种复杂疾病采用多学科方法。

相似文献

1
Diffuse Pleural Mesothelioma: Advances in Molecular Pathogenesis, Diagnosis, and Treatment.弥漫性胸膜间皮瘤:分子发病机制、诊断和治疗的进展。
Annu Rev Pathol. 2024 Jan 24;19:11-42. doi: 10.1146/annurev-pathol-042420-092719. Epub 2023 Sep 18.
2
Genomic profiling of malignant peritoneal mesothelioma reveals recurrent alterations in epigenetic regulatory genes BAP1, SETD2, and DDX3X.恶性腹膜间皮瘤的基因组分析揭示了表观遗传调控基因BAP1、SETD2和DDX3X的复发性改变。
Mod Pathol. 2017 Feb;30(2):246-254. doi: 10.1038/modpathol.2016.188. Epub 2016 Nov 4.
3
Inactivation of Cooperates with Losses of and to Drive the Development of Pleural Malignant Mesothelioma in Conditional Mouse Models.Cooper 失活与 和 缺失协同作用驱动条件性小鼠模型中胸膜恶性间皮瘤的发展。
Cancer Res. 2019 Aug 15;79(16):4113-4123. doi: 10.1158/0008-5472.CAN-18-4093. Epub 2019 May 31.
4
The Rocky Road from Preclinical Findings to Successful Targeted Therapy in Pleural Mesothelioma.从临床前发现到胸膜间皮瘤靶向治疗的艰难历程。
Int J Mol Sci. 2022 Nov 3;23(21):13422. doi: 10.3390/ijms232113422.
5
Hemizygous loss of NF2 detected by fluorescence in situ hybridization is useful for the diagnosis of malignant pleural mesothelioma.荧光原位杂交检测 NF2 杂合性缺失有助于恶性胸膜间皮瘤的诊断。
Mod Pathol. 2020 Feb;33(2):235-244. doi: 10.1038/s41379-019-0309-6. Epub 2019 Jun 23.
6
Usefulness of NF2 hemizygous loss detected by fluorescence in situ hybridization in diagnosing pleural mesothelioma in tissue and cytology material: A multi-institutional study.荧光原位杂交检测NF2半合子缺失在组织和细胞学材料中诊断胸膜间皮瘤的实用性:一项多机构研究。
Lung Cancer. 2023 Jan;175:27-35. doi: 10.1016/j.lungcan.2022.11.013. Epub 2022 Nov 19.
7
Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis.抑癌基因改变通过 p53-miR-34a-c-Met 轴合作驱动富含肿瘤干细胞的侵袭性间皮瘤。
Cancer Res. 2014 Feb 15;74(4):1261-1271. doi: 10.1158/0008-5472.CAN-13-2062. Epub 2013 Dec 26.
8
Genome-wide analysis of abdominal and pleural malignant mesothelioma with DNA arrays reveals both common and distinct regions of copy number alteration.利用DNA阵列对腹部和胸膜恶性间皮瘤进行全基因组分析,揭示了拷贝数改变的共同区域和不同区域。
Cancer Biol Ther. 2016;17(3):328-35. doi: 10.1080/15384047.2016.1145850. Epub 2016 Feb 6.
9
The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma.BAP1、NF2和CDKN2A在恶性腹膜间皮瘤中的预后意义。
Mod Pathol. 2016 Jan;29(1):14-24. doi: 10.1038/modpathol.2015.121. Epub 2015 Oct 23.
10
Clinicopathologic and genetic characteristics of young patients with pleural diffuse malignant mesothelioma.胸膜弥漫性恶性间皮瘤年轻患者的临床病理和遗传学特征。
Mod Pathol. 2018 Jan;31(1):122-131. doi: 10.1038/modpathol.2017.108. Epub 2017 Sep 8.

引用本文的文献

1
Pipeline to evaluate YAP-TEAD inhibitors indicates TEAD inhibition represses -mutant mesothelioma.评估YAP-TEAD抑制剂的流程表明,TEAD抑制可抑制-突变型间皮瘤。
Life Sci Alliance. 2025 Jul 31;8(10). doi: 10.26508/lsa.202503241. Print 2025 Oct.
2
Delayed Diagnosis of Peritoneal Mesothelioma in Recurrent Ascites: A Case Report.复发性腹水型腹膜间皮瘤的延迟诊断:一例报告
Am J Case Rep. 2025 Apr 6;26:e946777. doi: 10.12659/AJCR.946777.
3
Bayesian analysis of the rate of spontaneous malignant mesothelioma among BAP1 mutant mice in the absence of asbestos exposure.
在无石棉暴露情况下对BAP1突变小鼠自发性恶性间皮瘤发生率的贝叶斯分析。
Sci Rep. 2025 Jan 2;15(1):169. doi: 10.1038/s41598-024-84069-w.
4
Malignant Mesothelioma: Overcoming Diagnostic Hurdles.恶性间皮瘤:克服诊断难题
Cureus. 2024 Sep 5;16(9):e68718. doi: 10.7759/cureus.68718. eCollection 2024 Sep.
5
BAP1 Loss, Nuclear Grading, and Nonepithelioid Features in the Diagnosis of Mesothelioma in Italy: Nevermore without the Pathology Report.意大利间皮瘤诊断中BAP1缺失、核分级及非上皮样特征:若无病理报告,绝不再如此。
J Pers Med. 2024 Apr 8;14(4):394. doi: 10.3390/jpm14040394.
6
Diffuse Pleural Mesotheliomas with Genomic Near-Haploidization: A Newly Recognized Subset with Distinct Clinical, Histologic, and Molecular Features.弥漫性胸膜间皮瘤伴基因组近单体性:一种新认识的具有独特临床、组织学和分子特征的亚群。
Clin Cancer Res. 2024 Jul 1;30(13):2780-2789. doi: 10.1158/1078-0432.CCR-24-0085.
7
The BAP1 nuclear deubiquitinase is involved in the nonhomologous end-joining pathway of double-strand DNA repair through interaction with DNA-PK.BAP1 核去泛素化酶通过与 DNA-PK 的相互作用参与双链 DNA 修复的非同源末端连接途径。
Oncogene. 2024 Apr;43(15):1087-1097. doi: 10.1038/s41388-024-02966-w. Epub 2024 Feb 21.